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Abstract
We studied ubiquinone (Q), Q homologue ratio and steady-state levels of mCOQ transcripts in
tissues from mice fed ad libitum or under calorie restriction. Maximum ubiquinone levels on a
protein basis were found in kidney and heart, followed by liver, brain and skeletal muscle. Liver
and skeletal muscle showed the highest Q9/Q10 ratios with significant inter-individual variability.
Heart, kidney, and particularly brain exhibited lower Q9/Q10 ratios and inter-individual variability.
In skeletal muscle and heart, the most abundant mCOQ transcript was mCOQ7, followed by
mCOQ8, mCOQ2, mPDSS2, mPDSS1 and mCOQ3. In non muscular tissues (liver, kidney and
brain) the most abundant mCOQ transcript was mCOQ2, followed by mCOQ7, mCOQ8, mPDSS1,
mPDSS2, and mCOQ3. Calorie restriction increased both ubiquinone homologues and mPDSS2
mRNA in skeletal muscle, but mCOQ7 was decreased. In contrast, Q9 and most mCOQ transcripts
were decreased in heart. Calorie restriction also modified Q9/Q10 ratio, which was increased in
kidney and decreased in heart without alterations of mPDSS1 or mPDSS2 transcripts. We
demonstrate for the first time that unique patterns of mCOQ transcripts exist in muscular and non-
muscular tissues, and that Q and COQ genes are targets of calorie restriction in a tissue-specific
way.
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1. Introduction
Ubiquinone (coenzyme Q, Q) is a prenylated benzoquinone which plays a fundamental role
shuttling electrons from Complex I and Complex II to Complex III in the mitochondrial
electron transport chain [1,2]. Other functions of Q include the mitochondrial oxidation of
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dihydroorotate in the pyrimidine biosynthesis pathway [3,4], protection against oxidative
stress as the only lipid-soluble antioxidant which is synthesized in all organisms [1,2], and
electron transport as a carrier in the transplasma membrane redox system [5]. A number of
proposed functions for Q are less defined from a molecular point of view. These include
modulating the sensitivity of mitochondrial uncoupling proteins (UCPs) to purine
nucleotides by Q redox state, regulating the mitochondrial permeability transition pore
activity [7], and inhibiting plasma membrane neutral sphingomyelinase [8]. Q is positioned
in a privileged position because it links basic aspects of cell physiology such as energy
metabolism, antioxidant protection, and the regulation of cell growth and death.
Although dietary Q is incorporated to some extent in particular tissues, under normal
conditions its de novo synthesis accounts for the majority of Q present in peripheral tissues
[1,2,9,10]. The precursor of the benzoquinone ring is 4-hydroxybenzoate, whereas the
synthesis of the isoprenoid side chain starts from acetyl-coenzyme A to yield farnesyl
pyrophosphate (FPP) through the mevalonate pathway [1,2,11]. The trans-prenyltransferase
activity, a tetramer composed of PDSS1 and PDSS2 gene products [12,13], catalyzes the
condensation of FPP with several units of isopentenyl pyrophosphate (IPP), all in trans
configuration, to form a long polyisoprenoid chain whose length, 9 or 10 isoprene units in
mammals, determines the actual isoform which is synthesized (Q9 or Q10, respectively)
[1,2]. Then, 4-hydroxybenzoate and polyprenyl pyrophosphate are condensed by polyprenyl
4-hydroxybenzoate transferase, encoded by COQ2 [14]. After condensation, at least six
enzymes (encoded by COQ3-8) catalyze C-hydroxylations, decarboxylation, O-
methylations, and C-methylation to synthesize Q [1,2].
Q distribution is not uniform among different tissues and organs, indicating that Q levels are
adapted to the particular physiology of the tissue. Since Q is rapidly broken down, as
reflected in its short half-life, actual levels of Q in tissues are likely determined by a
coordinated balance between synthesis and degradation, both of which occur in all tissues
[1,2]. In mice, rats and humans, maximal Q concentrations are present in kidney and heart,
while lower amounts can be detected in liver, brain and skeletal muscle [1,15-19]. Since Q
redistribution between organs appears insignificant [2], tissue-specific mechanisms must
exist to determine actual levels of Q in any given tissue. However, the control of Q
distribution in tissues is not fully understood.
Since Q plays a central role in energy metabolism, alterations in Q biosynthesis may
participate in adaptive responses to physiological, experimental or pathological conditions
shown to modify Q levels in tissues. Q is increased under cold adaptation and with exercise,
while it may be decreased by aging, at least in some tissues [2]. Calorie restriction (CR) is
the most robust intervention that improves healthspan and extends lifespan in many animal
models [20-22]. Thus, previous investigations have also studied putative changes of Q levels
with CR. In this regard, it has been reported that long-term CR increases total Q in
mitochondria from skeletal muscle, liver, heart and kidney [23,24].
Because of the complex pathway leading to Q synthesis, simultaneously examining Q levels
and several COQ mRNAs or proteins in different tissues can give us novel insights to
understand genetic factors which determine tissue-specific distribution of Q and its
modulation during metabolic adaptation. However, previous studies have focused on single
COQ genes under normal conditions, and data are only available for COQ3 [10], COQ2 [14]
and COQ7 [25-28]. The possibility that CR influences Q biosynthesis has not yet been
investigated, since none of the previous studies examining Q changes with CR were focused
on COQ mRNAs or proteins. We hypothesized that specific patterns of COQ mRNA levels
might be identified in tissues, and that these mRNA patterns could be modulated by CR. To
test this hypothesis we systematically evaluated the profile of Q9 and Q10 and steady-state
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COQ mRNAs levels in different tissues of animals fed ad libitum (AL) or under CR. We
demonstrate for the first time that muscular and non-muscular tissues display unique
patterns of mCOQ transcripts, and that Q and COQ genes are targets of CR in a tissue-
specific way, supporting the idea that alterations of Q biosynthesis are part of the metabolic
adaptation to CR in mice.
2. Materials and Methods
Unless otherwise indicated, all chemicals were purchased from Sigma (Spain).
2.1. Animals, tissue samples and ethics statement
A cohort of 32 ten week old C57BL/6 were used (Charles River Laboratories, Spain). Male
C57BL/6 mice were bred and raised in a vivarium at the Centro Andaluz de Biología del
Desarrollo (CABD) under a 12h light/dark cycle (8:00 AM-8:00 PM) under controlled
conditions of temperature (22 ± 3°C) and humidity. The animals were fed an AIN93G diet.
Food intake was measured during 1 month to determine the average amount of food
consumed per day. At 3 months of age, animals were randomly divided into AL (95% of
average diary intake) or CR (60% average diary intake) groups. Filtered and acidified water
was available ad libitum for all groups and food was replaced with every day between
8:00-9:00 am. Animals were fed for 1 month under these conditions, and then sacrificed
after an 18 hour fast by cervical dislocation. Samples from liver, kidney, brain, skeletal
muscle (gastrocnemius) and heart were taken, frozen in liquid nitrogen, and stored at −80°C
for later analysis. Animals were handled in accordance with the Pablo de Olavide University
Ethical Committee rules, and the 86/609/EEC Directive on the protection of animals used
for experimental and other scientific purposes.
2.2. Quantification of steady-state levels of COQ transcripts
Quantification of mRNA steady-state copy number was carried out by quantitative real time
RT-PCR (qrtRT-PCR), where samples were run against synthetic standards. Total RNA was
obtained from tissues using the Absolutely RNA RT-PCR Miniprep Kit (Stratagene, La
Jolla, CA) and then reverse transcribed using the cDNA First Strand Synthesis kit (MRI
Fermentas, Hanover, MD). Primers were selected using genomic sequences obtained from
Genbank (National Center for Biotechnology Information (NCBI)) and Primer 3 software
[29]. Specific primer sequences for COQ and housekeeping genes (glyceraldehyde-3-
phosphate dehydrogenase – mGAPDH, hypoxanthine ribosyltransferase – mHPRT, and 18S
ribosomal RNA – m18S) measured in this study, with indication of GenBank accession
numbers and product sizes, are given in Table I.
Primers were used in a standard PCR with cDNA from the tissue of interest as template
using the 2× Master Mix PCR reagent (MRI Fermentas). Products were run on agarose gels
to confirm that only one band was amplified and no primer dimers were formed. PCR
products were then column-purified (QIAGEN, Valencia, CA) and sequenced to confirm
target specificity. The concentration of purified products generated by standard PCR was
then determined using Molecular Probe’s Picogreen DNA quantification kit, and serial
dilutions of PCR products were carried out to obtain standards containing 101, 102, 103, 104,
105, 106 and 108 copies of synthetic template. To determine the starting copy number of
cDNA, samples were amplified by qrtRT-PCR using SYBR PCR Master Mix (Bio-Rad
Laboratories, Hercules, CA). Thermocycling and fluorescence detection was performed
according to standard protocols using a Bio-Rad real-time PCR machine. The signal
obtained from a given tissue cDNA was compared with that of a standard curve run on the
same plate. In addition, total RNA samples that were not reverse transcribed and a no-DNA
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control were run on each plate to control for genomic DNA contamination and to monitor
potential exogenous contamination, respectively.
To determine if the selected housekeeping genes were appropriate as internal controls, the
stability of expression was calculated using the GeNorm 3.3 Visual basic application for
Microsoft Excel (http://medgen.ugent.be/~jvdesomp/genorm/) to calculate the average
pairwise variation of a particular gene with all other control genes (M value) as previously
developed and validated [30]. In our study, calculation of the M values for the three control
genes assessed revealed that mGAPDH and m18S levels were the least stable under all
conditions. Therefore, M values were recalculated using mHPRT where all M values were
<1.5. Therefore, the copy numbers for this gene within each sample were used as
normalization factors (NF). Results were then reported as [median (minimum–maximum) of
COQ genes copy number minus background] / NF.
2.3. Lipid extraction and Q quantification
A total lipid fraction was obtained from the tissues (about 30 mg fresh weight) by
homogenization in 90 μl of Hank’s solution to which 10 μl of 10% SDS had been added to
facilitate disruption of the membranes. Afterwards, two volumes of 95% ethanol–5%
isopropanol were added and the mixture was vigorously vortexed. Q was recovered from
SDS-alcoholic solution by extraction with five volumes of hexane. After hexane evaporation
under vacuum, the lipid extract was dissolved in a 1:1 mixture of methanol and n-propanol
and then used for quantification of Q9 and Q10 by reversed-phase HPLC separation with a
C18 column (25 × 0.45 cm, 5 μm particle size).
HPLC separation was accomplished at 1 ml/min with a mobile phase composed of a mixture
of methanol and n-propanol (1:1) containing lithium perchlorate (2.12 g/L). Monitoring was
carried out with a Coulochem II electrochemical detector (ESA, Chelmsford, MA) fitted
with a Model 5010 analytical cell with the electrodes set at potentials of −500 mV and +300
mV. Quinones were detected from the signal obtained at the second electrode.
Concentrations were calculated by integration of peak areas and comparison with external
standards (Sigma, Madrid, Spain).
2.4. SDS-PAGE and immunodetection of Coq2p and Coq3p
For immunodetection of Coq2p and Coq3p polypeptides, protein (about 100 μg) was
denatured by heating at 45°C during 15 min in SDS-dithiothreitol loading buffer (10%
sucrose, 2 mM EDTA, 1.5% (w/v) SDS, 20 mM dithiothreitol, 0.01% (w/v) bromophenol
blue and 60 mM Tris–HCl (pH 6.8)) containing 1 mM PMSF and 20 μg/μl each of
chymostatin, leupeptin, antipain and pepstatin A. Proteins were separated by SDS-PAGE
(10% acrylamide) and then transferred to nitrocellulose sheets. Blots were stained with
Ponceau S for visualization of protein lanes. Density of staining with Ponceau’s was used as
a control for protein loading as described [31]. Immunostaining of western blots was carried
out with chicken polyclonal anti-sera raised against the protein of interest and diluted at
1:2000. A horseradish peroxidase-conjugated anti-chicken IgG secondary antibody (Sigma)
diluted at 1:5000 was used to reveal binding sites by enhanced chemiluminiscence.
Photographic films and Ponceau S-stained blots were scanned in a GS-800 calibrated
densitometer (Bio-Rad) to obtain digital images. Quantification of intensity reaction was
carried out using Quantity One software (Bio-Rad). Data obtained from quantification of
stained bands (in arbitrary units) were normalized to that of the corresponding lane stained
with Ponceau S in order to correct for any difference in protein loading between samples.
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2.5. Statistical analysis
For gene expression and Q quantification studies, samples from all conditions within an
experiment were processed at the same time, and therefore the in vivo effects of diet were
assessed by Student’s t test (vs. corresponding controls). The effects of diet on different
tissues in C57BL/6 mice were assessed by one-way ANOVA followed by analysis of
significant differences with Tukey’s test for multiple comparisons. In case this test was
found inappropriate for our purposes we used Duncan’s non-parametric test. P < 0.05 was
considered significant. All values are expressed as mean ± SEM. All statistical analyses
were performed using the SPSS 11.0 software package (Chicago, USA) and STATISTICA
8.0. P values less than 0.05 were considered significant.
3. Results and Discussion
3.1. Ubiquinone distribution in mouse tissues
We first evaluated Q distribution in different mouse tissues. For this study we chose both
mitotic (liver, kidney) and postmitotic (brain, skeletal muscle, heart) tissues and organs. As
depicted in Figure 1A, the highest concentration of Q9 on a protein basis was found in
kidney, followed by heart, liver, brain and skeletal muscle. In the case of Q10, the order
(from maximal to minimal Q concentration) was kidney, heart, brain, liver, and skeletal
muscle (Figure 1B). Differences in Q distribution among tissues were very high, which
agrees with previous reports for the same tissues and organs obtained from mice [16-18] or
rats [19]. For instance, when we compared kidney versus skeletal muscle, differences could
be as high as 20-fold in the case of Q9 and 100-fold in the case of Q10. Lower content of Q
in gastrocnemius muscle than in heart was expected since gastrocnemius contains abundant
fast-twitch glycolytic fibres and much less mitochondria than heart [32]. In accordance,
differences between skeletal muscle and heart are much lower when measuring Q9 and Q10
in isolated mitochondria [18,19,23].
Q9/Q10 ratios also displayed significant variability among tissues and organs in the mouse.
Highest Q9/Q10 ratios were observed in liver and skeletal muscle (mean values of about 19
and 15, respectively), although inter-individual variability was also very high. A lower Q9/
Q10 ratio (mean value of 8.6) was found in heart, which also showed lower individual
variability. Kidney and brain exhibited both the lowest Q9/Q10 ratios (mean values of 4.6
and 2.7, respectively) and the lowest variability among individuals, particularly in the case
of brain, where all Q9/Q10 values were contained within an extremely narrow range (Figure
1C). This observation supports the idea that the homeostatic range for Q isoforms varies
among tissues and organs, and the maintenance of a given Q9/Q10 ratio may be important for
proper function of organs, particularly brain, showing a relatively high Q10 content.
3.2. Steady-state levels of COQ transcripts in tissues
One of our major aims was to systematically evaluate steady-state levels of COQ transcripts
in different mouse tissues. No previous study has applied qrtRT-PCR to provide a reliable
estimate of steady-state levels of several COQ transcripts. Previous studies have also not
investigated the relationship between levels of several COQ transcripts and Q distribution in
the same tissues. We focused our study on genes encoding proteins of known or putative
function in Q biosynthesis for which inactivating mutations that result in Q deficiency have
been observed in humans [2]. These included mPDSS1 and mPDSS2, the two subunits of
polyprenyl diphosphate synthase; mCOQ2, the polyprenyl-4-hydroxybenzoate transferase
which catalyzes the first enzymatic step that is specific for Q biosynthesis, and mCOQ8 /
ADCK3, a putative kinase [1,2]. In addition, we also included in our study two additional
COQ genes with well-established function in Q biosynthesis: mCOQ3 and mCOQ7. COQ3
encodes 2,3-dihydroxy-5-polyprenylbenzoate-methyl transferase, which is responsible for
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the two O-methylations steps in the production of Q, the last of these yielding the final
product [10,33,34]. COQ7/Clk-1 encodes an hydroxylase which catalyzes the conversion of
5-demethoxy-Q to hydroxy-Q, the penultimate step of Q biosynthesis [35], and plays a
prominent role in determining life span in vertebrate and invertebrate animal models [36].
We demonstrate here for the first time that tissues can be grouped according to steady-state
levels of COQ transcripts (Figure 2) into two basic patterns: muscular and non muscular.
Among the transcripts studied, mCOQ7 was the most abundant in gastrocnemius and heart,
followed by mCOQ8, mCOQ2, mPDSS2, mPDSS1 and mCOQ3. However, despite
exhibiting a similar pattern of mCOQ transcripts, the two muscular tissues differed by
almost one order of magnitude in Q levels (see Figures 1 and 2). The striking similarity
between the transcript patterns of gastrocnemius and heart supports the idea that the
difference of Q content is due to post-transcriptional mechanisms which drive Q
biosynthesis rate, the amount of mitochondria, and probably the catabolic rates of Q
degradation [2]. The two mitotic organs studied, liver and kidneys, displayed an almost
identical pattern of steady-state COQ transcripts levels. Maximal abundance was observed
for mCOQ2, followed by mCOQ7, mCOQ8, mPDSS1, mPDSS2, and mCOQ3. The pattern
of COQ transcripts in brain was similar to those of liver and kidneys, although the absolute
number of copies of COQ transcripts was lower (Figure 2). Of note, compared with other
mCOQ mRNAs, steady-state levels of mCOQ3 transcripts were very low in non muscular
tissues.
Very few studies have addressed the tissue distribution of COQ transcripts, and none have
analyzed simultaneously several COQ genes by means of a quantitative and reliable
technique, such as qrtRT-PCR. Previous studies have focused on single COQ genes, and
data are only available for COQ2, COQ3, and COQ7. Forsgren et al. [14] cloned the human
COQ2 gene and studied tissue distribution of hCOQ2 transcript using dot blot with a
radioactive probe in a commercial array for human mRNA. Maximal levels of hCOQ2
mRNA were detected in muscle and heart tissue, which agrees with our results. However,
the abundance of hCOQ2 transcript was considerable lower in kidney, as well as in other
non muscular tissues. Here we show that mCOQ2 transcripts can be found at comparable
levels in kidney and muscular tissues. This discrepancy could be due to species specificity
(human vs mouse). The study of Marbois et al. [10] was focused on tissue distribution of
COQ3 mRNA in the rat, using Northern blot with a radioactive probe. Steady-state levels of
COQ3 mRNA were studied in brain, heart, kidney, liver, skeletal muscle and testis. Rat
COQ3 mRNA was particularly abundant in testis, heart and thigh muscle, followed in order
of abundance by kidney, brain and liver, which agrees with our study. Finally, a number of
studies have addressed the distribution of COQ7 mRNA in several human and mouse
tissues. These studies have demonstrated that hCOQ7 mRNA is found predominantly in
heart and skeletal muscle, whereas very low levels are present in brain, placenta, liver,
kidney, pancreas and lung [25,37]. In mice, mCOQ7 mRNA was particularly abundant in
heart, skeletal muscle and kidney [27], which also agrees with our results.
We report here that the mRNAs encoding for the two subunits of the polyprenyl diphosphate
synthase (mPDSS1 and mPDSS2) were particularly abundant in muscular tissues. PDSS1
and PDSS2 have been proposed to play an important role in determining Q levels because
the polyprenyl diphosphate synthase is the branch-point enzyme that utilizes FPP in the
terminal part of Q biosynthesis, a process which is considered limited by the availability of
polyisoprenoid chain precursor [2]. However, steady-state levels of mPDSS1 and mPDSS2
transcripts were similar in kidney and liver, two organs whose Q content differed
substantially (see Figure 1), suggesting the existence of post-transcriptional levels of
regulation. It is also possible that a limited amount of mPDSS1 and mPDSS2 transcripts is
sufficient to provide enough polyisoprenoid chain precursor in these two mitotic organs, the
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higher concentration of Q in kidney being determined by a higher amount of mitochondria
[2]. Transgenic mice harboring an overexpression of mutated PDSS2 isoform showed a
kidney defect associated with Q deficiency that was partially rescued by Q supplementation
[13].
3.3. Tissue patterns of Coq2 and Coq3 polypeptides
Of note, mCOQ3 transcripts varied substantially among the different tissues irrespective of
their Q levels (see Figures 1 and 2). The lack of correlation between mCOQ3 transcripts and
Q levels in tissues has been explained on the basis of the existence of post-transcriptional
controls [10]. However, no study has been designed to date to test this hypothesis. Thus, we
were interested in analyzing tissue levels of mCoq3 polypeptide to investigate if protein
levels followed those of mRNA. Our study at the protein level also included mCoq2p.
Although increased in kidney, heart and skeletal muscle, steady-state levels of mCOQ2 in
tissues were more homogeneous than those of mCOQ3 (see Figure 2).
As depicted in Figure 3, mCoq2p levels were higher in tissues and organs which showed the
highest levels of mCOQ2 transcripts. Maximal levels of Coq2p were detected in heart and
kidney, the two organs showing the highest levels of Q, followed by skeletal muscle. The
lowest levels of mCoq2p were detected in brain and liver, which also showed lower steady-
state levels of mCOQ2 transcripts. With respect to mCoq3p, maximal levels were detected in
heart, while this polypeptide was found at significantly lower amounts in liver, kidney,
skeletal muscle and brain. It is noteworthy that differences between the latter four tissues in
terms of steady-state levels of mCOQ3 transcripts were of up to 3 orders of magnitude (if we
compare skeletal muscle versus brain) whereas similar levels of mCoq3p were found in
these tissues, demonstrating a strong regulation at a post-transcriptional level, as previously
suggested [10]. The relatively low level of mCoq3p in kidney is very interesting because this
organ showed by far the highest levels of Q9 and Q10. Although Coq3p catalyzes two steps
in Q biosynthesis, the last of them yielding the final product [10,33,34], the low levels of
mCOQ3 RNA and mCoq3p in kidney is consistent with a non limiting role for Coq3p in Q
biosynthesis. In accordance, it has been suggested that Q levels in tissues are regulated at the
initial steps in the terminal part of Q biosynthesis. Competitive inhibition of Coq2p by p-
hydroxybenzoate analogues readily decreases Q levels in cellular systems [38,39],
supporting an important role for Coq2p in the overall regulation of Q synthesis.
Furthermore, there was no correlation between levels of Coq7p (which catalyzes the
penultimate step of Q biosynthesis) and those of Q in a mouse model of transgene mCOQ7
expression [28]. However, the Coq7 reaction is apparently a point of regulation of Q
biosynthesis pathway in yeast by post-transcriptional modification of either Coq7p or any
component of the biosynthesis pre-complex [40].
3.4. The effect of calorie restriction on Q tissue levels
One month of 40% CR produced changes in the absolute levels of Q in muscular tissues
(Figure 1). An increase of both Q9 and Q10 was detected in skeletal muscle, whereas a
decrease of Q9 with no change in Q10 was detected in heart. In addition, the Q9/Q10 ratio
was increased in kidney but decreased in heart. Previous reports have shown that long-term
CR increased Q9 content of mitochondria isolated from skeletal muscle [23], liver, heart and
kidney [24], although another study reported that CR induced a decrease of Q9 and Q10 in
liver mitochondria [41]. The increase of Q9 by CR in skeletal muscle mitochondria [23]
agrees with our results, although we also observed an increase of Q10, and these changes
were detected very early, after one month of CR. Our results are in agreement with
Bevilacqua et al. [42], who demonstrated that skeletal muscle (but not liver) mitochondria
are rapidly adapted to short-term (2-wk and 2-mo) CR in the rat with a significant decrease
of ROS generation [43]. It is possible that CR effects on Q in liver are a late event since life-
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long CR attenuated the increase of Q9/Q10 ratio in rat liver plasma membrane from aged rats
[44].
Very few pharmacological treatments or physiological conditions are known to produce
significant increases of Q in tissues, and most of them are related with oxidative stress
conditions. An early work described increases in the contents of Q in liver and, to some
extent, in kidney and muscle of rats treated with peroxisome proliferators, without
modifying cholesterol levels [45]. More recently, it was reported that camptothecin and
other chemotherapeutic drugs, such as etoposide, doxorubicin, and methotrexate, increased
Q10 levels in tumour cells as part of an antioxidant response [46]. Finally, the mono and
diepoxy derivatives of α- γ-tocotrienols are strong stimulators of Q biosynthesis [2]. The
CR-induced increase of Q9 and Q10 in skeletal muscle is unique because it is associated with
decreased oxidative stress [42]. In addition to alterations in the abundance of mCOQ
transcripts (see below), a more reduced status might lead to higher Q levels in skeletal
muscle due to reduced oxidative degradation.
The effects of CR on Q levels and Q9/Q10 ratio in heart are noteworthy because these
modifications might be associated with alterations in mitochondrial function. Interestingly,
ubisemiquinone-derived ROS are believed to be involved in Ca2+-stimulated
permeabilization of mitochondria due to the opening of the permeability transition pore
(PTP) [47], and quinones are well known modulators of the PTP [48,49]. Interestingly,
short-term (2 mo) CR produced a small (14%) decrease in ROS production by heart
ventricular subsarcolemmal mitochondria isolated from 6 mo male F344 rats [50], and
counteracted the age-related loss in their Ca2+ retention capacity [51]. It is tempting to
speculate that the CR-induced changes of the Q system we show here could be related with
some of the beneficial effects of CR on the mitochondrial physiology in heart. However, it
has to be acknowledged that CR produced opposite effects on Q levels in kidney, which
points to the existence of different mechanisms of regulation in this mitotic organ compared
with heart.
The Q9/Q10 ratio is determined by the polyisoprenoid substrate available for the reaction
catalyzed by the polyprenyl 4-hydroxybenzoate transferase. The actual products of the
trans-prenyltransferase activity (nona- or decaprenylpyrophosphate) are determined by the
ratio between FPP and IPP, giving more decaprenylpyrophosphate in the presence of high
IPP-Mg2+ [52]. Thus, our observations that CR increased Q9/Q10 ratio in kidney but
decreased it in heart might indicate the existence of alterations in IPP/FPP ratio under CR
conditions.
3.5. Effect of calorie restriction on steady-state COQ transcripts and Coq2 and Coq3
polypeptides
We next studied how calorie restriction affected steady-state levels of COQ transcripts in
tissues. As depicted in Figure 4, the abundance of mCOQ transcripts was affected by CR in
a tissue-specific manner. The response of the two mitotic tissues to CR included a modest
increase of some mCOQ transcripts: mCOQ2, mCOQ3, mCOQ7 and mCOQ8 in liver, and
mCOQ2 and mCOQ7 in kidney. If we compare these results with those obtained for Q
levels, we can conclude that the limited changes of mRNAs detected in liver and kidney
were not sufficient to produce significant alterations of Q levels. No changes in mPDSS1 or
mPDSS2 transcripts were observed in kidney from CR mice. A mutation in PDSS1 has been
demonstrated to decrease significantly Q10 without affecting Q9 levels in humans [53].
Muscular tissues were affected by CR in a different way. In skeletal muscle mPDSS2 was
increased, whereas COQ7 was decreased. The increase of mPDSS2 in skeletal muscle
coincided with a significant increase of Q9 and Q10 levels (see above). Camptothecin-
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induced increase of Q10 levels in cellular systems was associated with up-regulation of
Coq7p expression, as part of an antioxidant response [46]. Increase of Q10 biosynthesis by
chemotherapeutic drugs is dependent on NF-κB that binds specifically to two κB binding
sites present in the 5′-flanking region of the COQ7 gene, inducing both the COQ7
expression and Q10 biosynthesis [54]. Here, we show that the CR-induced increase of Q
levels in skeletal muscle is not dependent on increased abundance of mCOQ7 mRNA but, on
the contrary, decreased steady-state levels of mCOQ7 with CR were found in this tissue. The
fact that CR can increase both steady-state levels of mPDSS2 and total Q in skeletal muscle
may be of importance because skeletal muscle is one of the specific sites of Q deficiency
and tissue damage caused by a mutation in the PDSS2 gene in humans [55]. In heart, the
general response was a decrease in many of the COQ transcripts analyzed, except for COQ7,
which showed a slight increase. The decrease of Q9 with CR in heart is consistent with
significant decreases of mPDSS2, mCOQ2, and mCOQ8 transcripts. A trend towards lower
levels was also observed for mPDSS1 and mCOQ3 in heart from CR mice, although
differences were not statistically significant. Remarkably, no change in steady-state levels of
any of the COQ transcripts was observed in brain, which coincided with the lack of changes
elicited by CR in Q levels.
We also studied putative variations in the amount of Coq2 and Coq3 polypeptides induced
by CR. For this analysis we only included the organs or tissues that exhibited some change
associated with CR, either in Q or COQ transcripts levels. As depicted in Figure 5, the
general tendency was either no change, or decreases of Coq2 and Coq3 polypeptides with
CR. Although Coq3p was decreased by CR in kidney, Coq2p was unchanged. As stated
above, steady-state abundance of mCOQ3 or Coq3p do not correlate with Q levels, and the
possibility exists that relatively low levels of Coq3p are sufficient to provide enough Q
biosynthesis. The lack of CR-induced changes for mCOQ2 and mCOQ3 transcripts in
skeletal muscle is consistent with the absence of changes at the level of protein, which
agrees with the idea that the increase of Q levels by short-term CR in skeletal muscle is
regulated at an early point, most likely by the availability of polyisoprenoid chain precursor
[2] and/or by a less oxidant status [42] which leads to decreased oxidative degradation. In
heart, the decrease in most mCOQ transcripts coincided with decreases of Coq2p and
Coq3p, suggesting that lower levels of Q9 in heart after 1 mo of CR may be the result of
decreased biosynthesis.
In summary we demonstrate for the first time that muscular and non-muscular tissues
display unique patterns of mCOQ transcripts, and that Q and COQ genes are targets of CR in
a tissue-specific way, supporting the idea that alterations of Q biosynthesis are part of the
metabolic adaptation to CR in mice.
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IPP isopentenyl pyrophosphate
NF normalization factor
PTP permeability transition pore
Q coenzyme Q, ubiquinone
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Figure 1.
Tissue distribution of Q homologues and Q9/Q10 ratio. Tissues (liver, kidney, brain, skeletal
muscle and heart) were taken from 4 mo old mice that had been fed ad libitum or under 1
mo CR. Quinones were recovered by organic extraction with hexane, and separated and
quantified by HPLC. A) Q9 levels. B) Q10 levels. C) Q9/Q10 ratio. Data are means ± SEM
(n=16). Significant differences between diets (ad libitum vs CR) are indicated by asterisks (*
p<0.05 ; ** p<0.01 ; ***p<0.001). Open bars, ad libitum; Closed bars : CR.
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Figure 2.
Patterns of steady-state levels of mCOQ transcripts in mouse tissues. RNA samples were
extracted from liver, kidney, brain, skeletal muscle and heart obtained from control animals
(fed ad libitum), and then used for reverse transcription and quantification of the absolute
number of mRNA copies by qrtRT-PCR. Primers are depicted in Table I. Results obtained
for mCOQ mRNAs were normalized to those of mHPRT as internal control. Data are means
± SEM (n=16).
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Figure 3.
Levels of Coq2p and Coq3p in mouse tissues. Samples of liver, kidney, brain, skeletal
muscle and heart were obtained from control animals (fed ad libitum), and then processed
for SDS-PAGE and immunodetection of the polypeptides of interest by Western blot.
Staining was repeated in three different preparations. This figure depicts the results of a
representative blot.
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Figure 4.
The effect of short-term (1 mo) CR on steady-state abundance of mCOQ mRNAs. RNA
samples were extracted from liver, kidney, brain, skeletal muscle and heart obtained from
animals fed ad libitum or under CR (1 mo). Samples were processed as described in Figure
2. Depicted results show the absolute number of copies of mCOQ mRNAs present in tissues
obtained from calorie-restricted animals, normalized to mHPRT and then referred to the
values obtained for the same tissue obtained from control animals (set to 100% in each
case). Data are means ± SEM (n=16). Open bars, ad libitum; Closed bars : CR.
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Figure 5.
The effect of short-term (1 mo) CR on steady-state abundance of Coq2p and Coq3p.
Samples of liver, kidney, brain, skeletal muscle and heart were obtained from control (fed ad
libitum) and from calorie-restricted animals, and then processed for SDS-PAGE and
immunodetection of the polypeptides of interest by Western blot. Staining was repeated in
three different preparations. This figure depicts the results of a representative blot. Open
bars, ad libitum; Closed bars : CR.
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Table I
Primers for qrtRT-PCR used in the study
PRIMERS SENSE (5′-3′) ANTI-SENSE (5′-3′) PRODUCT
SIZE (BP)
GENBANK
ACCESSION NO.
mHPRT CAGTCAACGGGGGACATAAA AGAGGTCCTTTTCACCAGCAA 183 NM_013556
mGAPDH ATGGCCTTCCGTGTTCCTAC GCCTGCTTCACCACCTTCTT 104 XM_194302
m18S TGACTCAACACGGGAAACCT AACCAGACAAATCGCTCCAC 125 X00686
mSPS1 CATCAAAGGACACCAGCAATGT GCACCACAATAATCGGTCTAAAGG 208 NM_019501
mDLP1 ATGCTGACCTCCAGCCTTTT GTCACACCTTTGCCAGCTTT 196 NM_027772
mCOQ2 GCCCACCAGGACAAGAAAGAC AGCCACAGCAGCGTAGTAGG 171 NM_027978
mCOQ3 GTGAGCCACCTGGAAATGTT CCCACGTATGAGTGCCTTTT 163 NM_172687
mCOQ7 TGATGGAAGAGGACCCTGAGAAG GCCTGTATCGTGGTGTTCAAGC 89 NM_009940
mCOQ8 AGCAAGCCACACAAGCAGATG CCAGACCTACAGCCAGACCTC 106 NM_023341
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